Technology Distributors
Compare Stocks
4 / 10Stock Comparison
IZM vs AVGO vs TXN vs MCHP
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
IZM vs AVGO vs TXN vs MCHP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Technology Distributors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $1M | $1.96T | $259.70B | $54.97B |
| Revenue (TTM) | $362M | $68.28B | $18.44B | $4.37B |
| Net Income (TTM) | $-667K | $24.97B | $5.37B | $-97M |
| Gross Margin | 2.8% | 67.1% | 57.3% | 51.6% |
| Operating Margin | -0.2% | 40.9% | 35.3% | 4.1% |
| Forward P/E | — | 36.5x | 37.8x | 64.8x |
| Total Debt | $12M | $65.14B | $15.39B | $5.67B |
| Cash & Equiv. | $2M | $16.18B | $3.23B | $772M |
IZM vs AVGO vs TXN vs MCHP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 23 | May 26 | Return |
|---|---|---|---|
| ICZOOM Group Inc. (IZM) | 100 | 22.2 | -77.8% |
| Broadcom Inc. (AVGO) | 100 | 643.1 | +543.1% |
| Texas Instruments I… (TXN) | 100 | 153.3 | +53.3% |
| Microchip Technolog… (MCHP) | 100 | 121.2 | +21.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IZM vs AVGO vs TXN vs MCHP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IZM lags the leaders in this set but could rank higher in a more targeted comparison.
AVGO carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 23.9%, EPS growth 287.8%, 3Y rev CAGR 24.4%
- 29.0% 10Y total return vs TXN's 471.6%
- 23.9% revenue growth vs MCHP's -42.3%
- Lower P/E (36.5x vs 64.8x)
TXN is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 22 yrs, beta 1.11, yield 1.9%
- Lower volatility, beta 1.11, Low D/E 94.6%, current ratio 4.35x
- Beta 1.11, yield 1.9%, current ratio 4.35x
- Beta 1.11 vs AVGO's 1.96
MCHP is the clearest fit if your priority is momentum.
- +115.1% vs IZM's -81.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.9% revenue growth vs MCHP's -42.3% | |
| Value | Lower P/E (36.5x vs 64.8x) | |
| Quality / Margins | 36.6% margin vs MCHP's -2.2% | |
| Stability / Safety | Beta 1.11 vs AVGO's 1.96 | |
| Dividends | 1.9% yield, 22-year raise streak, vs MCHP's 1.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +115.1% vs IZM's -81.6% | |
| Efficiency (ROA) | 15.5% ROA vs IZM's -1.5%, ROIC 15.8% vs -4.1% |
IZM vs AVGO vs TXN vs MCHP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IZM vs AVGO vs TXN vs MCHP — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVGO leads in 2 of 6 categories
TXN leads 2 • IZM leads 1 • MCHP leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVGO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVGO is the larger business by revenue, generating $68.3B annually — 188.4x IZM's $362M. AVGO is the more profitable business, keeping 36.6% of every revenue dollar as net income compared to MCHP's -2.2%. On growth, AVGO holds the edge at +29.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $362M | $68.3B | $18.4B | $4.4B |
| EBITDAEarnings before interest/tax | $184,236 | $38.8B | $8.1B | $881M |
| Net IncomeAfter-tax profit | -$666,903 | $25.0B | $5.4B | -$97M |
| Free Cash FlowCash after capex | $2M | $28.9B | $3.7B | $820M |
| Gross MarginGross profit ÷ Revenue | +2.8% | +67.1% | +57.3% | +51.6% |
| Operating MarginEBIT ÷ Revenue | -0.2% | +40.9% | +35.3% | +4.1% |
| Net MarginNet income ÷ Revenue | -0.2% | +36.6% | +29.1% | -2.2% |
| FCF MarginFCF ÷ Revenue | +0.4% | +42.3% | +20.2% | +18.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.0% | +29.5% | +18.6% | +15.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | +31.6% | +32.0% | +164.2% |
Valuation Metrics
IZM leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 52.3x trailing earnings, TXN trades at a 39% valuation discount to AVGO's 86.5x P/E. On an enterprise value basis, TXN's 33.9x EV/EBITDA is more attractive than AVGO's 58.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1M | $1.96T | $259.7B | $55.0B |
| Enterprise ValueMkt cap + debt − cash | $11M | $2.00T | $271.9B | $59.9B |
| Trailing P/EPrice ÷ TTM EPS | -1.74x | 86.49x | 52.34x | -9999.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 36.45x | 37.76x | 64.79x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.73x | — | — |
| EV / EBITDAEnterprise value multiple | — | 58.52x | 33.89x | 57.21x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 30.62x | 14.69x | 12.49x |
| Price / BookPrice ÷ Book value/share | 0.26x | 24.63x | 16.00x | 7.71x |
| Price / FCFMarket cap ÷ FCF | 0.76x | 72.67x | 99.77x | 71.19x |
Profitability & Efficiency
TXN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
AVGO delivers a 32.9% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-4 for IZM. IZM carries lower financial leverage with a 0.79x debt-to-equity ratio, signaling a more conservative balance sheet compared to TXN's 0.95x. On the Piotroski fundamental quality scale (0–9), AVGO scores 8/9 vs MCHP's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.3% | +32.9% | +32.5% | -1.4% |
| ROA (TTM)Return on assets | -1.5% | +14.9% | +15.5% | -0.7% |
| ROICReturn on invested capital | -4.1% | +14.9% | +15.8% | +1.8% |
| ROCEReturn on capital employed | -8.6% | +16.9% | +19.0% | +2.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.79x | 0.80x | 0.95x | 0.80x |
| Net DebtTotal debt minus cash | $10M | $49.0B | $12.2B | $4.9B |
| Cash & Equiv.Liquid assets | $2M | $16.2B | $3.2B | $772M |
| Total DebtShort + long-term debt | $12M | $65.1B | $15.4B | $5.7B |
| Interest CoverageEBIT ÷ Interest expense | -0.31x | 9.24x | 12.06x | 0.78x |
Total Returns (Dividends Reinvested)
AVGO leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVGO five years ago would be worth $93,355 today (with dividends reinvested), compared to $1,158 for IZM. Over the past 12 months, MCHP leads with a +115.1% total return vs IZM's -81.6%. The 3-year compound annual growth rate (CAGR) favors AVGO at 88.2% vs IZM's -47.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -85.1% | +18.9% | +62.3% | +56.9% |
| 1-Year ReturnPast 12 months | -81.6% | +102.6% | +76.5% | +115.1% |
| 3-Year ReturnCumulative with dividends | -85.9% | +566.4% | +83.5% | +43.9% |
| 5-Year ReturnCumulative with dividends | -88.4% | +833.6% | +65.5% | +45.7% |
| 10-Year ReturnCumulative with dividends | -88.4% | +2897.3% | +471.6% | +373.8% |
| CAGR (3Y)Annualised 3-year return | -47.9% | +88.2% | +22.4% | +12.9% |
Risk & Volatility
Evenly matched — IZM and MCHP each lead in 1 of 2 comparable metrics.
Risk & Volatility
IZM is the less volatile stock with a -0.74 beta — it tends to amplify market swings less than AVGO's 1.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MCHP currently trades 98.5% from its 52-week high vs IZM's 14.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.74x | 1.96x | 1.11x | 1.70x |
| 52-Week HighHighest price in past year | $2.74 | $437.68 | $292.64 | $103.17 |
| 52-Week LowLowest price in past year | $0.34 | $198.43 | $152.73 | $46.92 |
| % of 52W HighCurrent price vs 52-week peak | +14.0% | +94.3% | +97.5% | +98.5% |
| RSI (14)Momentum oscillator 0–100 | 41.4 | 68.0 | 79.6 | 82.5 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 23.3M | 6.7M | 9.0M |
Analyst Outlook
TXN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AVGO as "Buy", TXN as "Buy", MCHP as "Buy". Consensus price targets imply 7.6% upside for AVGO (target: $444) vs -14.4% for MCHP (target: $87). For income investors, TXN offers the higher dividend yield at 1.92% vs AVGO's 0.56%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $443.72 | $253.71 | $87.00 |
| # AnalystsCovering analysts | — | 58 | 65 | 46 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% | +1.9% | +1.8% |
| Dividend StreakConsecutive years of raises | — | 16 | 22 | 5 |
| Dividend / ShareAnnual DPS | — | $2.30 | $5.48 | $1.82 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.3% | +0.6% | +0.2% |
AVGO leads in 2 of 6 categories (Income & Cash Flow, Total Returns). TXN leads in 2 (Profitability & Efficiency, Analyst Outlook). 1 tied.
IZM vs AVGO vs TXN vs MCHP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IZM or AVGO or TXN or MCHP a better buy right now?
For growth investors, Broadcom Inc.
(AVGO) is the stronger pick with 23. 9% revenue growth year-over-year, versus -42. 3% for Microchip Technology Incorporated (MCHP). Texas Instruments Incorporated (TXN) offers the better valuation at 52. 3x trailing P/E (37. 8x forward), making it the more compelling value choice. Analysts rate Broadcom Inc. (AVGO) a "Buy" — based on 58 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IZM or AVGO or TXN or MCHP?
On trailing P/E, Texas Instruments Incorporated (TXN) is the cheapest at 52.
3x versus Broadcom Inc. at 86. 5x. On forward P/E, Broadcom Inc. is actually cheaper at 36. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IZM or AVGO or TXN or MCHP?
Over the past 5 years, Broadcom Inc.
(AVGO) delivered a total return of +833. 6%, compared to -88. 4% for ICZOOM Group Inc. (IZM). Over 10 years, the gap is even starker: AVGO returned +29. 0% versus IZM's -88. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IZM or AVGO or TXN or MCHP?
By beta (market sensitivity over 5 years), ICZOOM Group Inc.
(IZM) is the lower-risk stock at -0. 74β versus Broadcom Inc. 's 1. 96β — meaning AVGO is approximately -367% more volatile than IZM relative to the S&P 500. On balance sheet safety, ICZOOM Group Inc. (IZM) carries a lower debt/equity ratio of 79% versus 95% for Texas Instruments Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — IZM or AVGO or TXN or MCHP?
By revenue growth (latest reported year), Broadcom Inc.
(AVGO) is pulling ahead at 23. 9% versus -42. 3% for Microchip Technology Incorporated (MCHP). On earnings-per-share growth, the picture is similar: Broadcom Inc. grew EPS 287. 8% year-over-year, compared to -229. 4% for ICZOOM Group Inc.. Over a 3-year CAGR, AVGO leads at 24. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IZM or AVGO or TXN or MCHP?
Broadcom Inc.
(AVGO) is the more profitable company, earning 36. 2% net margin versus -1. 3% for ICZOOM Group Inc. — meaning it keeps 36. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVGO leads at 39. 9% versus -0. 8% for IZM. At the gross margin level — before operating expenses — AVGO leads at 67. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IZM or AVGO or TXN or MCHP more undervalued right now?
On forward earnings alone, Broadcom Inc.
(AVGO) trades at 36. 5x forward P/E versus 64. 8x for Microchip Technology Incorporated — 28. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVGO: 7. 6% to $443. 72.
08Which pays a better dividend — IZM or AVGO or TXN or MCHP?
In this comparison, TXN (1.
9% yield), MCHP (1. 8% yield), AVGO (0. 6% yield) pay a dividend. IZM does not pay a meaningful dividend and should not be held primarily for income.
09Is IZM or AVGO or TXN or MCHP better for a retirement portfolio?
For long-horizon retirement investors, ICZOOM Group Inc.
(IZM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 74)). Broadcom Inc. (AVGO) carries a higher beta of 1. 96 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IZM: -88. 4%, AVGO: +29. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IZM and AVGO and TXN and MCHP?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IZM is a small-cap quality compounder stock; AVGO is a mega-cap high-growth stock; TXN is a large-cap quality compounder stock; MCHP is a mid-cap quality compounder stock. AVGO, TXN, MCHP pay a dividend while IZM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.